Tritonpoint Wealth LLC Has $7.39 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Tritonpoint Wealth LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,115 shares of the healthcare conglomerate’s stock after selling 215 shares during the quarter. Tritonpoint Wealth LLC’s holdings in UnitedHealth Group were worth $7,393,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of UNH. Geode Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock valued at $10,068,869,000 after buying an additional 319,515 shares during the last quarter. Capital International Investors lifted its holdings in shares of UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock valued at $7,899,905,000 after buying an additional 906,365 shares during the last quarter. Norges Bank acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $6,375,744,000. Northern Trust Corp lifted its holdings in shares of UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock valued at $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. lifted its holdings in shares of UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after buying an additional 861,854 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In related news, CEO Stephen J. Hemsley acquired 86,700 shares of the company’s stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares of the company’s stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer now owns 10,398 shares of the company’s stock, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders bought a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. 0.28% of the stock is owned by insiders.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $313.39 on Friday. The stock’s fifty day simple moving average is $386.66 and its 200 day simple moving average is $474.19. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market cap of $284.28 billion, a price-to-earnings ratio of 20.22, a P/E/G ratio of 1.37 and a beta of 0.45. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the firm posted $6.91 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.82%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is currently 37.02%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on UNH. Erste Group Bank downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. JPMorgan Chase & Co. cut their price objective on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research note on Thursday, May 15th. Royal Bank of Canada dropped their price target on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a research report on Friday, May 16th. Bank of America downgraded UnitedHealth Group from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. Finally, Baird R W downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $426.52.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.